Systematic review / meta-analysis / 2014
Garlic powder supplementation significantly reduced total cholesterol, LDL-C, fasting blood glucose, and blood pressure in randomized clinical trials.
A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.
- Study type
- Meta-analysis of randomized controlled clinical trials
- Who was studied
- Participants across 4 to 22 randomized controlled trials depending on the outcome
- What was measured
- Total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure (SBP and DBP)
THE PAPER
Garlic powder intake and cardiovascular risk factors: a meta-analysis of randomized controlled clinical trials.
Kwak JS, Kim JY, Paek JE, Lee YJ, Kim HR, Park DS, Kwon O. Nutr Res Pract, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.